Phase 3 double-blind placebo-controlled randomized trial of Z-100 in patients with radiation therapy for cervical cancer

Status

Unknown

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080220032

Enrollment

240

Registered

2005-09-06

Start date

2005-09-06

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary cervical cancer patients treated with radiotherapy

Interventions

investigational material(s) Generic name etc : Z-100 INN of investigational material : Therapeutic category code : 429 Other antitumor agents Dosage and Administration for Investigational material :

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Inclusion Criteria: -Patients with FIGO Stage IIb - IVa. -Patients with squamous cell carcinoma histologically. Exclusion Criteria: -Patients with complication of cancers in addition to cervical cancer or patients who undergo the therapy. -Patients who contracted the cancers except for cervical cancer within 5 years.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Survival	—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026